NYSE (USD): Dr. Reddy's Laboratories Limited (RDY)
Last Price
78.68
Today's Change
+0.43 (0.54%)
Day's Change
78.51 - 79.21
Trading Volume
41,084
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Stock Price
238
1000
110
900
600
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
Uniqlo Owner Targets Higher Sales From Strong Western Market
2
OpenAI Starts Hiring in Singapore for Second Office in Asia
3
Higher Food Prices Lift US Consumer Prices; Hurricane Helene Boosts Jobless Claims
4
US Considers Breakup of Google in Landmark Search Case
5
Meta Launches Generative AI Video Tools for Advertisers
#
Stock
Score
PLTR
Palantir Technologies Inc.
BABA
Alibaba Group Holding Limited
AAPL
Apple Inc.
SCC
ProShares UltraShort Consumer Services
687
ETE
625
6
AGN
7
CAT
Caterpillar Inc.
8
NEON
Neonode Inc.
9
XIDE
First Trust Exchange-Traded Fund Viii - Cboe Vest U S Equity Buffer and Premium Income Etf
10
UFS
Domtar Corporation
312
Last
Change
Volume
TVGN
1.17
+0.79
203,872,862
NVDA
138.51
+3.71
136,556,433
LMDX
0.016
-0.018
120,553,903
GRTS
0.061
+0.01
117,320,719
JTAI
0.109
+0.008
91,743,524
762.00
-84.71
85,558,284
SQQQ
7.01
-0.157
74,778,950
SOFI
9.86
+0.855
64,048,897
TSLA
219.55
+1.75
61,503,683
TSLL
9.56
+0.16
59,649,096
BRK-A
692,782.56
+1,282.56
1,437
NVR
9,644.33
+110.14
1,804
PABD
55.56
+55.56
QOWZ
33.13
+33.13
449
BLCR
31.85
+31.85
BELT
30.25
+30.25
153
ASML
869.07
+28.38
1,092,386
QMID
27.95
+27.95
NSCR
27.77
+27.77
0
TXSS
27.58
+27.58
1,126
MELI
1,629.32
-188.66
1,851,535
MSTR
1,309.00
-138.99
2,237,917
MKL
1,395.13
-102.30
318,280
MPWR
838.63
-96.05
902,546
NOW
643.29
-87.83
5,025,012
MEDP
357.30
-79.88
1,004,401
MDB
236.06
-73.94
10,812,930
MCK
547.51
-70.00
4,067,959
OLED
172.28
-40.39
1,254,445
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....